Investment Advisor Sells $6.6 Million Worth of Medical Solutions Stock, According to Recent SEC Filing [Yahoo! Finance]
Omnicell, Inc. (OMCL)
Last omnicell, inc. earnings: 2/6 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.omnicell.com
Company Research
Source: Yahoo! Finance
Omnicell (NASDAQ:OMCL) , an estimated $6.55 million transaction based on the quarterly average price. What happened According to its SEC filing dated April 29, 2026, Avory & Company, LLC reduced its position in Omnicell by 156,571 shares, an estimated $6.55 million transaction based on the average first-quarter 2026 closing price. The quarter-end value of the Omnicell stake declined by $8.01 million, a figure that reflects both the reduction in shares and Omnicell's price movement over the period. The fund's post-sale holding in Omnicell was 77,137 shares, valued at $2.57 million. What else to know Following the sale, Omnicell represents 3.33% of Avory & Company, LLC's reportable assets under management. Top five holdings after the filing: NYSEMKT: VOO: $17.22 million (22.3% of AUM) NASDAQ: ZM: $8.59 million (11.1% of AUM) NYSE: XYZ: $7.41 million (9.6% of AUM) BATS: AVRY: $7.29 million (9.4% of AUM) NASDAQ: Z: $4.27 million (5.5% of AUM) As of April 28, 2026, Om
Show less
Read more
Impact Snapshot
Event Time:
OMCL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OMCL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OMCL alerts
High impacting Omnicell, Inc. news events
Weekly update
A roundup of the hottest topics
OMCL
News
- Omnicell (OMCL) had its "buy" rating reaffirmed by Craig Hallum.MarketBeat
- Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical OfficerBusiness Wire
- Why Omnicell Stock Trounced the Market on Tuesday [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Why Omnicell Stock Trounced the Market on Tuesday [Yahoo! Finance]Yahoo! Finance
- Omnicell (OMCL) Q1 2025 Earnings Transcript [Yahoo! Finance]Yahoo! Finance
OMCL
Earnings
- 4/28/26 - Beat
OMCL
Sec Filings
- 4/29/26 - Form SCHEDULE
- 4/28/26 - Form 8-K
- 4/13/26 - Form ARS
- OMCL's page on the SEC website